1. Home
  2. HRMY vs NRP Comparison

HRMY vs NRP Comparison

Compare HRMY & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • NRP
  • Stock Information
  • Founded
  • HRMY 2017
  • NRP 2002
  • Country
  • HRMY United States
  • NRP United States
  • Employees
  • HRMY N/A
  • NRP N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • NRP Coal Mining
  • Sector
  • HRMY Health Care
  • NRP Energy
  • Exchange
  • HRMY Nasdaq
  • NRP Nasdaq
  • Market Cap
  • HRMY 1.5B
  • NRP 1.4B
  • IPO Year
  • HRMY 2020
  • NRP N/A
  • Fundamental
  • Price
  • HRMY $31.40
  • NRP $105.60
  • Analyst Decision
  • HRMY Strong Buy
  • NRP
  • Analyst Count
  • HRMY 9
  • NRP 0
  • Target Price
  • HRMY $50.44
  • NRP N/A
  • AVG Volume (30 Days)
  • HRMY 912.0K
  • NRP 24.5K
  • Earning Date
  • HRMY 11-04-2025
  • NRP 11-04-2025
  • Dividend Yield
  • HRMY N/A
  • NRP 2.84%
  • EPS Growth
  • HRMY 50.44
  • NRP N/A
  • EPS
  • HRMY 3.17
  • NRP 10.92
  • Revenue
  • HRMY $825,944,000.00
  • NRP $203,316,000.00
  • Revenue This Year
  • HRMY $20.68
  • NRP N/A
  • Revenue Next Year
  • HRMY $15.93
  • NRP N/A
  • P/E Ratio
  • HRMY $9.92
  • NRP $9.66
  • Revenue Growth
  • HRMY 21.13
  • NRP N/A
  • 52 Week Low
  • HRMY $25.52
  • NRP $86.83
  • 52 Week High
  • HRMY $40.93
  • NRP $113.04
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 63.59
  • NRP 52.84
  • Support Level
  • HRMY $27.66
  • NRP $102.06
  • Resistance Level
  • HRMY $30.96
  • NRP $107.00
  • Average True Range (ATR)
  • HRMY 1.25
  • NRP 2.73
  • MACD
  • HRMY 0.54
  • NRP 0.08
  • Stochastic Oscillator
  • HRMY 92.89
  • NRP 58.03

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.

Share on Social Networks: